The FDA Approves Obinutuzumab (Gazyva) for Previously Untreated Advanced Follicular Lymphoma

The FDA approves the use of obinutuzumab (Gazyva) in combination with chemotherapy, for treatment of previously untreated advanced follicular lymphoma patients.  More >

Image: